ReviewPhilosophical transactions of the Royal Society of London. Series B, Biological sciences2014
Sources, impacts and trends of pharmaceuticals in the marine and coastal environment.
Review in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
61 citing papers in PubMed, 455 citations in OpenAlex.
- Aquatic Bacterial Community Responses to Aquatic Contaminants Revealed by 16S rRNA Metabarcoding in Field-Based Microcosms.Environmental microbiology reports · 2026Article
- Occurrence and concentration of caffeine and cadmium as micropollutants in the Red Sea coast, Egypt.Scientific reports · 2026Article
- Teaching the true cost of medicines: white paper for a green and sustainable pharmacology curriculum.Frontiers in pharmacology · 2026Review
- Adsorption Performance Assessment of Agro-Waste-Based Biochar for the Removal of Emerging Pollutants from Municipal WWTP Effluent.Molecules (Basel, Switzerland) · 2025Article
- Pharmaceutical compounds in marine ecosystems: ecotoxicological effects and risk assessment in phytoplankton and zooplankton.Ecotoxicology (London, England) · 2025Article
- Factors Affecting Distribution of Pharmaceutically Active Compounds in Bottom Sediments of Odra River Estuary (SW Baltic Sea).Molecules (Basel, Switzerland) · 2025Article
- Exposure to metoprolol and propranolol mixtures on biochemical, immunohistochemical, and molecular alterations in the American oyster,Toxicology reports · 2025Article
- Distribution of pharmaceuticals in marine surface sediment and macroalgae (ulvophyceae) around Mombasa peri-urban creeks and Gazi Bay, Kenya.Environmental science and pollution research international · 2025Article
- Article
- Environmental risk and market approval for human pharmaceuticals.Monash bioethics review · 2024Article
- Occurrence and environmental risk assessment of pharmaceuticals in the Mondego river (Portugal).Heliyon · 2024Article
- Article
- Exposure to environmental pharmaceuticals affects the macromolecular composition of mussels digestive glands.Scientific reports · 2024Article
- Factors Determining the Susceptibility of Fish to Effects of Human Pharmaceuticals.Environmental science & technology · 2023Review
- Analysis of Antibiotics in Bivalves by Ultra-High Performance Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry.Antibiotics (Basel, Switzerland) · 2023Article
- Article
- Elucidating the Effects of the Lipids Regulators Fibrates and Statins on the Health Status of Finfish Species: A Review.Animals : an open access journal from MDPI · 2023Review
- Anchialine pool shrimp (Halocaridina rubra) as an indicator of sewage in coastal groundwater ecosystems on the island of Hawai'i.PloS one · 2023Article
- Digital Video Acquisition and Optimization Techniques for Effective Animal Tracking in Behavioral Ecotoxicology.Environmental toxicology and chemistry · 2022Article
- Review
1 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There has been a significant investment in research to define exposures and potential hazards of pharmaceuticals in freshwater and terrestrial ecosystems. A substantial number of integrated environmental risk assessments have been developed in Europe, North America and many other regions for these situations. In contrast, comparatively few empirical studies have been conducted for human and veterinary pharmaceuticals that are likely to enter coastal and marine ecosystems. This is a critical knowledge gap given the significant increase in coastal human populations around the globe and the growth of coastal megacities, together with the increasing importance of coastal aquaculture around the world. There is increasing evidence that pharmaceuticals are present and are impacting on marine and coastal environments. This paper reviews the sources, impacts and concentrations of pharmaceuticals in marine and coastal environments to identify knowledge gaps and suggests focused case studies as a priority for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.